Dabrafenib in combination with RC48 in BRAF positive melanoma cell lines

Поделиться
HTML-код
  • Опубликовано: 7 фев 2025
  • The content of this video is based on BMC's publication of Weisong et al., 2024 "Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma".
    Μεταγραφή

Комментарии •